Edward Fisher

Felicita Andreotti2
Robin Youngs2
Anne Tybjærg-Hansen2
Learn More
  • Børge G. Nordestgaard, M. John Chapman, Kausik Ray, Jan Borén, Felicita Andreotti, Gerald F. Watts +13 others
  • 2010
AIMS The aims of the study were, first, to critically evaluate lipoprotein(a) [Lp(a)] as a cardiovascular risk factor and, second, to advise on screening for elevated plasma Lp(a), on desirable levels, and on therapeutic strategies. METHODS AND RESULTS The robust and specific association between elevated Lp(a) levels and increased cardiovascular disease(More)
Even at low-density lipoprotein cholesterol (LDL-C) goal, patients with cardiometabolic abnormalities remain at high risk of cardiovascular events. This paper aims (i) to critically appraise evidence for elevated levels of triglyceride-rich lipoproteins (TRLs) and low levels of high-density lipoprotein cholesterol (HDL-C) as cardiovascular risk factors, and(More)
  • 1